Amarin Corp Plc (AMRN)

[KCSVEN]

I agree, getting a handle on Anchor market potential is extremely difficult. I think Lovaza has been very aggressive off label and very successful at getting some insurance coverage off label, I'm not sure insurance companies were paying much attention until last year on off label payment, just paying the tier 2 for the drug. Based on old posts the reps were selling off label from day 1.

But Lovaza IS limited on what they can say and what they can advertise so off label useage, you would think, would be a fraction of potential market.

Many High Trig people will look to exercise and other OTC options before going for a prescription so the percent of high trig population getting a prescription should be less than the percent of Very High trig population.

But what the real available market is in Anchor is really a wide range. There are few scenarios where it would not lead to a stock price 15 or higher but what that # is and how fast they penetrate the market determines if upside is 15 or 50. Just seems to be no way to get a good handle on that.